Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05148936 · ClinicalTrials.gov registry record · NA
Communities Fighting COVID-19!
A NA study of COVID-19, sponsored by San Diego State University.
- Completed
- Registry status
- NA
- Development phase
- 32,750
- Enrollment target
- 1
- Study location
NCT05148936: Completed NA study of COVID-19, sponsored by San Diego State University.
NCT05148936 is a NA study of COVID-19 that has completed, run by San Diego State University. The registered enrollment target is 32,750 participants, below the 38,355-participant average among 298 other COVID-19 trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05148936, a NA study of COVID-19, has completed, sponsored by San Diego State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32,750 participants
- Enrollment target
- 1
- Study location
Study Summary
To create and evaluate effective COVID-19 testing uptake strategies that focus on underserved individuals who are exposed but have not accessed testing, and underserved individuals who are not routinely tested because they are unaware of their exposure or risk status in order to increase testing among these populations and reduce Covid-19 related disparities.
Primary Outcome
Testing volume by study arm as cumulative count per hours testing site operated
Conditions Studied
Interventions
- OTHER COVID-19 Testing Home-based (Aim 1)
- OTHER COVID-19 Testing Mobile (Aim 1)
- OTHER COVID-19 Testing Mobile Approach 1 (Aim 2)
- OTHER COVID-19 Testing Mobile Approach 2 (Aim 2)
Study Locations (1)
California
- Contact Households - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32,750 participants |
| Start Date | 2020-10-25 |
| Est. Completion | 2023-08-25 |
| Phase | NA |
What the finished NCT05148936 record still lists
NCT05148936 is an interventional study that assigns participants to a tested intervention. Its 32,750 participants enrollment target places it among the larger protocols in the corpus, below the 38,355-participant average among 298 other COVID-19 trials with a reported enrollment target (15% lower).
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 4 interventions - of which COVID-19 Testing Home-based (Aim 1) is the first listed.
NCT05148936 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05148936 about?
NCT05148936 is a clinical study titled "Communities Fighting COVID-19!". To create and evaluate effective COVID-19 testing uptake strategies that focus on underserved individuals who are exposed but have not accessed testing, and underserved individuals who are not routinely tested because they are unaware of their exposure or risk status in order to increase testing amo...
What is the current status of trial NCT05148936?
This trial is currently completed. It is a NA study. The enrollment target is 32,750 participants. The study started on 2020-10-25. Estimated completion is 2023-08-25.
What conditions does trial NCT05148936 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT05148936?
The interventions under investigation include: COVID-19 Testing Home-based (Aim 1) (OTHER), COVID-19 Testing Mobile (Aim 1) (OTHER), COVID-19 Testing Mobile Approach 1 (Aim 2) (OTHER), COVID-19 Testing Mobile Approach 2 (Aim 2) (OTHER).
Who is sponsoring clinical trial NCT05148936?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05148936 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05148936's enrollment target sits among peer trials
32,750 10th of 298 higher than 289 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04477928 · 33,000 participants
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
- NCT06145724 · 33,183 participants · NA
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
- NCT07282665 · 32,000 participants · Phase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI